ACRO BIOMEDICAL CO., LTD. (ACBM)
2025-06-30 | ||||
|---|---|---|---|---|
| Revenues | - | |||
| Selling, general and administrative | 13,614 | |||
| Total operating expenses | 13,614 | |||
| Loss from operations | -13,614 | |||
| Interest expense - related parties | 1,948 | |||
| Total other expenses | 1,948 | |||
| Loss before income tax expense | -15,562 | |||
| Income tax expense | - | |||
| Net loss | -15,562 | |||
| Basic and diluted loss per share of common stock | - | |||
| Weighted average number of shares of common stock outstanding | 60,042,000 | |||